Press "Enter" to skip to content

Oligonucleotide Synthesis Market Share, Size 2019-2024 | Industry Analysis, Overview of Market Dynamics, Top Key Players, and Regional Forecast to 2024

Oligonucleotide

The “Oligonucleotide Synthesis Market” report 2019 covers all the significant developments which are recently being adopted across the global market. The prime objective of Oligonucleotide Synthesis market report is to provides an in-depth analysis of all market dynamics including drivers and restraints, and trends and opportunities. The Oligonucleotide Synthesis market report covers both the demand and supply aspect of the market. The report also highlighted the future trends in the Oligonucleotide Synthesis market that will impact the demand during the forecast period.

Scope of the Report:

  • As per the , oligonucleotides are short fragments of nucleic acids that are synthesized using genetic engineering and enzyme chemistry. These are mostly used in laboratories in applications, such as therapeutic, diagnostics, as well as academic and industrial. These are used from initial research and screening through to target validation and drug production. Nowadays, subsequent improvements in oligonucleotide synthesis, amplification, and automation have completely revolutionized biological research. It is also possible to do the customizations and get the required sequence online easily and at the required time. These services vary greatly by the cost of per base pair, error rates, lengths, throughput, etc.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14099009

    Market Overview:

  • The growth of the oligonucleotide synthesis market is due to the increasing government investments and R&D expenditure in pharmaceutical and biotechnology companies and the use of synthesized oligonucleotides in molecular diagnostics and clinical applications.
  • The usage of synthetic oligonucleotides has been increasing rapidly over the past decade, owing to several benefits offered by molecular diagnostics and growing clinical applications. The nucleic acid application techniques are the reference methods and are very useful for carrying out the molecular diagnosis in several diseases, like for the detection of infectious diseases, such as hepatitis.
  • Synthetic oligonucleotides also have significant clinical applications, primarily for the detection of autoimmune antibodies. There have been consistent developments in synthetic biology over the past few years, where synthetic oligonucleotides were used to develop assays for the detection of anti-double-stranded DNAs. Thus, all these factors are responsible for the growth of the oligonucleotide synthesis market.
  • In addition, there are also other major factors influencing the market for oligonucleotide synthesis. This includes the increasing advancement in the field of healthcare, increasing demand for innovation in the field of life science and medical academics, increasing investment by the government for the development of genomic technologies, and the increasing demand for oligonucleotide synthesis technologies by the public and private research firms.

    Some of the Top Key Players of Oligonucleotide Synthesis Market Report Are:

  • Agilent Technologies
  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio
  • Synthesis Inc.
  • Eurofins Genomics
  • Eurogentec
  • GE Healthcare
  • GenScript
  • Integrated DNA Technologies Inc.
  • LGC Biosearch Technologies

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    For More Information or Query or Customization Before Buying, Visit athttps://www.industryresearch.co/enquiry/pre-order-enquiry/14099009

    Key Market Trends:

    Academic Research Institutes are the Largest Segment Under End User that is Expected to Grow in the Forecast Period

    The government and private entities are found investing in the development of academic and research infrastructure in the emerging economies. This factor is positively boosting the oligonucleotide adoption in academic research institutes. There is an increase in the genomic research projects conducted by academic research institutes that have enabled the segment to account for the dominant share in the market.

    North America is the Largest Growing Segment and is Expected to Follow the Same Trend Over the Forecast Period

    North America dominates the market due to the presence of better health care infrastructure and increasing usage of oligonucleotides by pharmaceutical companies of the region. Furthermore, the strong foothold of North America in genomics, proteomics, oncology, diagnostic screening, and drug discovery has significantly contributed to maintaining its large share.

    The Report Covers:

    • Comprehensive research methodology of Oligonucleotide Synthesis market
    • In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
    • Analysis of regional regulations and other government policies impacting the global sleep aid market
    • Insights about market determinants which are stimulating the global Oligonucleotide Synthesis market
    • Detailed and extensive market segments with regional distribution of forecasted revenues
    • Extensive profiles and recent developments of market players Companies Mentioned

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14099009

    Detailed TOC of Oligonucleotide Synthesis Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
    4.2.2 The Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
    4.3 Market Restraints
    4.3.1 Price Erosion of Synthesized Oligonucleotides
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Product Type
    5.1.1 By Synthesized Oligonucleotide Product
    5.1.1.1 Primers
    5.1.1.2 Probes
    5.1.1.3 Large-scale Synthesis Oligonucleotides
    5.1.1.4 Intermediate-scale Synthesis Oligonucleotides
    5.1.1.5 Other Synthesized Oligonucleotide Product Types
    5.1.2 By Reagents
    5.1.3 By Equipment
    5.2 By Application
    5.2.1 By Research
    5.2.1.1 PCR
    5.2.1.1.1 QPCR
    5.2.1.1.2 Sequencing
    5.2.1.1.3 Gene Synthesis
    5.2.1.1.4 Other Research Application
    5.2.2 By Diagnostics
    5.2.3 By Therapeutics
    5.2.3.1 RNAi
    5.2.3.2 Nucleic Acid Aptamers
    5.2.3.3 DNA/Antisense Oligonucleotides
    5.2.3.4 Other Therapeutics
    5.3 By End User
    5.3.1 Academic Research Institutes
    5.3.2 Pharmaceutical and Biotechnology Companies
    5.3.3 Diagnostic Laboratories
    5.4 Geography
    5.4.1 North America
    5.4.1.1 US
    5.4.1.2 Canada
    5.4.1.3 Mexico
    5.4.2 Europe
    5.4.2.1 Germany
    5.4.2.2 UK
    5.4.2.3 France
    5.4.2.4 Italy
    5.4.2.5 Spain
    5.4.2.6 Rest of Europe
    5.4.3 Asia-Pacific
    5.4.3.1 China
    5.4.3.2 Japan
    5.4.3.3 India
    5.4.3.4 Australia
    5.4.3.5 South Korea
    5.4.3.6 Rest of Asia-Pacific
    5.4.4 Middle East & Africa
    5.4.4.1 GCC
    5.4.4.2 South Africa
    5.4.4.3 Rest of Middle East & Africa
    5.4.5 South America
    5.4.5.1 Brazil
    5.4.5.2 Argentina
    5.4.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Agilent Technologies
    6.1.2 Thermo Fisher Scientific
    6.1.3 Merck KGaA
    6.1.4 Bio-Synthesis Inc.
    6.1.5 Eurofins Genomics
    6.1.6 Eurogentec
    6.1.7 GE Healthcare
    6.1.8 GenScript
    6.1.9 Integrated DNA Technologies Inc.
    6.1.10 LGC Biosearch Technologies

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Feed Yeast Market 2019: Global Size, Industry Share, Outlook, Trends Evaluation, Geographical Segmentation, Business Challenges and Opportunity Analysis till 2024

    Voice Over Internet Protocol Market Share, Size 2019| Emerging Rapidly with Global Latest Trends, Growth, Revenue, Demand and Forecast to 2024

    Cable Assembly Market 2019: Production and Consumption Value, Import and Export Data with Forecast 2024

    Polyamide (PA) Market Size & Share 2019 – 2023 Business Strategy, Development Plans, Global Growth Rate by Manufacturers, and Forecast Analysis till 2023

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *